AS asks the sort of probing questions anyone on this board would ask, good on him. As far as the responses are concerned they seem a mixture of being guarded, apologetic and annoyed, intriguing.
What has changed so dramatically to bring these down by £3.00 a share in a year? At the very worst the Co is going to make the same profit as 2018 financial year.
Just to clarify. Your Trading Isa with II On transferring are the individual stocks in your portfolio sold and repurchased or is the process just a name change of provider ? I was looking at iweb £25 initial fee £5 dealing, extra charges can be involved. Very basic platform. Not for novice traders DYOR
On the basis of cash balance and forward costs at that time it was stated they see themselves as a going concern for the next 12 months . With cash on balance in the US being further diluted ( strength of £ ) and the increase in trial costs and further testing, the scenario of news sp and further news points to a funding raise. It has to happen at some time of course to keep progressing the research. Could it be sooner than later?